Publications

Sort by: [ Author  (Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Baptista, P. V. "Nanodiagnostics: leaving the research lab to enter the clinics?" Diagnosis (Berl) 1 (2014): 305-309. AbstractWebsite

n/a

Baptista, P., G. Doria, A. Matias, L. Osorio, E. Pereira, and F. Ricardo. Direct detection of mutations/SNPs using DNA-derivatised gold nanoparticles In Congress of Clinical Chemistry and Laboratory Medicine. Jena, Germany, 2005.
Baptista, Pedro V., Gonçalo Doria, Pedro Quaresma, Miguel Cavadas, Cristina S. Neves, Inês Gomes, Peter Eaton, Eulália Pereira, and Ricardo Franco. "Nanoparticles in molecular diagnostics. Nanoparticles in Translational Science and Medicine." In Progress in Molecular Biology and Translational Science, edited by A. Villaverde and Michael P. Conn. Elsevier, 2012.
Bao, Chenchen, Joao Conde, Ester Polo, Pablo del Pino, Maria Moros, Pedro V. Baptista, Valeria Grazu, Daxiang Cui, and Jesus M. de la Fuente. "A promising road with challenges: where are gold nanoparticles in translational research?" Nanomedicine 9 (2014): 2353-2370. Abstract

n/a

A
Alves-Barroco, C., L. Rivas-García, A. R. Fernandes, and P. V. Baptista. "Tackling Multidrug Resistance in Streptococci - From Novel Biotherapeutic Strategies to Nanomedicines." Front Microbiol 11 (2020): 579916. AbstractWebsite

n/a

Alves, Pedro Urbano, Raquel Vinhas, Alexandra R. Fernandes, Semra Zuhal Birol, Levent Trabzon, Iwona Bernacka-Wojcik, Rui Igreja, Paulo Lopes, Pedro Viana Baptista, Hugo Águas, Elvira Fortunato, and Rodrigo Martins. "Multifunctional microfluidic chip for optical nanoprobe based RNA detection – application to Chronic Myeloid Leukemia." Scientific Reports 8 (2018): 381. AbstractWebsite

Many diseases have their treatment options narrowed and end up being fatal if detected during later stages. As a consequence, point-of-care devices have an increasing importance for routine screening applications in the health sector due to their portability, fast analyses and decreased cost. For that purpose, a multifunctional chip was developed and tested using gold nanoprobes to perform RNA optical detection inside a microfluidic chip without the need of molecular amplification steps. As a proof-of-concept, this device was used for the rapid detection of chronic myeloid leukemia, a hemato-oncological disease that would benefit from early stage diagnostics and screening tests. The chip passively mixed target RNA from samples, gold nanoprobes and saline solution to infer a result from their final colorimetric properties. An optical fiber network was used to evaluate its transmitted spectra inside the chip. Trials provided accurate output results within 3 min, yielding signal-to-noise ratios up to 9 dB. When compared to actual state-of-art screening techniques of chronic myeloid leukemia, these results were, at microscale, at least 10 times faster than the reported detection methods for chronic myeloid leukemia. Concerning point-of-care applications, this work paves the way for other new and more complex versions of optical based genosensors.

Almeida, J., C. Roma-Rodrigues, A. G. Mahmoud, M. F. C. Guedes da Silva, A. J. L. Pombeiro, D.RS L. M. Martins, P. V. Baptista, and A. R. Fernandes. "Structural characterization and biological properties of silver(I) tris(pyrazolyl)methane sulfonate." J Inorg Biochem 199 (2019): 110789. AbstractWebsite

n/a